Galderma Proposes Board Appointments and CFO Transition
Galderma announced proposed board appointments and a chief financial officer transition.
Related stories
Hillman Reports Q3 2026 Results, Updates Full-Year Outlook
Q3 net sales rose 7.7% to a record. Hillman reiterated its FY 2026 adjusted EBITDA and free cash flow guidance and updated its net sales outlook.
M impact | EQUITY | Nov 02, 2026, 09:43 PM UTC
People Incorporated Reports 6% Q3 Decline in Session-Based Revenue
People Incorporated said session-based revenue declined 6% in Q3, reflecting accelerated impact from AI-oriented search and content discovery experiences.
M impact | EQUITY | Nov 02, 2026, 09:33 PM UTC
BRC Q3 Revenue Beats on Wholesale Strength
M impact | EQUITY | Nov 02, 2026, 09:33 PM UTC
EverQuote Sees Q4 2026 Revenue of $213M-$223M
M impact | EQUITY | Nov 02, 2026, 09:32 PM UTC
Transocean Reports $8.0B Backlog and 95% 2027 Contract Coverage
Management also said $200 million of Deepwater Aquila notes debt was retired ahead of schedule. The supplied text gives no Q3 2026 financial figures.
M impact | EQUITY | Nov 02, 2026, 09:32 PM UTC
Pershing Square Reports Third-Quarter 2026 Results
Pershing Square reported its third-quarter 2026 results; its earnings release and presentation are available.
M impact | EQUITY | Nov 02, 2026, 09:32 PM UTC